Regenerative cartilage therapy targets EU launch

co.don AG currently markets its regenerative therapy methods in Germany, where uptake is increasing among orthopedic surgeons, trauma surgeons and neurosurgeons.

Like Comment
Page of
Go to the profile of co.don


co.don AG, a fully integrated biopharmaceutical company, is a leading specialist in autologous cell cultivation (i.e., using the patient’s own cells) for the regenerative treatment of articular cartilage defects and spinal disc defects.

No comments yet.